267 related articles for article (PubMed ID: 33630393)
1. Tranexamic acid in patients with complex stones undergoing percutaneous nephrolithotomy: a randomised, double-blinded, placebo-controlled trial.
Batagello CA; Vicentini FC; Monga M; Miller AW; Marchini GS; Torricelli FCM; Danilovic A; Coelho RF; Srougi M; Nahas WC; Mazzucchi E
BJU Int; 2022 Jan; 129(1):35-47. PubMed ID: 33630393
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled randomized clinical trial to evaluate the efficacy of tranexamic acid in irrigant solution on blood loss during percutaneous nephrolithotomy: a pilot study from tertiary care center of North India.
Bansal A; Arora A
World J Urol; 2017 Aug; 35(8):1233-1240. PubMed ID: 27995302
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid for percutaneous nephrolithotomy.
Cleveland B; Norling B; Wang H; Gandhi V; Price CL; Borofsky MS; Pais V; Dahm P
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD015122. PubMed ID: 37882229
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid for percutaneous nephrolithotomy: an abridged Cochrane review.
Cleveland B; Norling B; Wang H; Gandhi V; Price CL; Borofsky M; Pais V; Dahm P
BJU Int; 2024 Mar; 133(3):259-272. PubMed ID: 38037865
[TBL] [Abstract][Full Text] [Related]
5. Re-evaluation of the efficacy of tranexamic acid in reducing blood loss in percutaneous nephrolithotomy: a randomized clinical trial.
Mohammadi Sichani M; Kazemi R; Nouri-Mahdavi K; Gholipour F
Minerva Urol Nefrol; 2019 Feb; 71(1):55-62. PubMed ID: 30037208
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of the tranexamic acid in reducing blood loss and transfusion requirements during percutaneous nephrolithotomy: a systematic review and meta-analysis of randomized controlled trials.
Feng D; Zhang F; Liu S; Han P; Wei W
Minerva Urol Nefrol; 2020 Oct; 72(5):579-585. PubMed ID: 32573173
[TBL] [Abstract][Full Text] [Related]
7. Can tranexamic acid reduce the blood transfusion rate in patients undergoing percutaneous nephrolithotomy? A systematic review and meta-analysis.
Wang Z; He X; Bai Y; Wang J
J Int Med Res; 2020 Apr; 48(4):300060520917563. PubMed ID: 32345081
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid reduces blood loss during percutaneous nephrolithotomy: a prospective randomized controlled study.
Kumar S; Randhawa MS; Ganesamoni R; Singh SK
J Urol; 2013 May; 189(5):1757-61. PubMed ID: 23123376
[TBL] [Abstract][Full Text] [Related]
9. Mini-percutaneous nephrolithotomy is a safe alternative to extracorporeal shockwave lithotripsy for high-density, renal stones: a prospective, randomised trial.
Ahmed AF; Abdelazim H; ElMesery M; El-Feky M; Gomaa A; Tagreda I; Abozied H; Fahim A
BJU Int; 2021 Dec; 128(6):744-751. PubMed ID: 34028170
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive percutaneous nephrolithotomy vs standard PCNL for management of renal stones in the flank-free modified supine position: single-center experience.
Sakr A; Salem E; Kamel M; Desoky E; Ragab A; Omran M; Fawzi A; Shahin A
Urolithiasis; 2017 Dec; 45(6):585-589. PubMed ID: 28229197
[TBL] [Abstract][Full Text] [Related]
11. The Efficacy and Safety of Tranexamic Acid in the Management of Perioperative Bleeding After Percutaneous Nephrolithotomy: A Systematic Review and Meta-Analysis of Comparative Studies.
Lee MJ; Kim JK; Tang J; Ming JM; Chua ME
J Endourol; 2022 Mar; 36(3):303-312. PubMed ID: 34569280
[No Abstract] [Full Text] [Related]
12. Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study.
Lundin ES; Johansson T; Zachrisson H; Leandersson U; Bäckman F; Falknäs L; Kjølhede P
Acta Obstet Gynecol Scand; 2014 Apr; 93(4):335-44. PubMed ID: 24428857
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Mini-Percutaneous Nephrolithotomy and Retrograde Intrarenal Surgery for Renal Pelvic Stones of 2-3 cm.
Erkoc M; Bozkurt M
J Laparoendosc Adv Surg Tech A; 2021 Jun; 31(6):605-609. PubMed ID: 33316204
[No Abstract] [Full Text] [Related]
14. Percutaneous nephrolithotomy versus open surgery for surgical treatment of patients with staghorn stones: A systematic review and meta-analysis.
Chen Y; Feng J; Duan H; Yue Y; Zhang C; Deng T; Zeng G
PLoS One; 2019; 14(1):e0206810. PubMed ID: 30703102
[TBL] [Abstract][Full Text] [Related]
15. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage.
Diprose P; Herbertson MJ; O'Shaughnessy D; Deakin CD; Gill RS
Br J Anaesth; 2005 Mar; 94(3):271-8. PubMed ID: 15591329
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial.
Crescenti A; Borghi G; Bignami E; Bertarelli G; Landoni G; Casiraghi GM; Briganti A; Montorsi F; Rigatti P; Zangrillo A
BMJ; 2011 Oct; 343():d5701. PubMed ID: 22012809
[TBL] [Abstract][Full Text] [Related]
17. Tranexamic acid in open aortic aneurysm surgery: a randomised clinical trial.
Monaco F; Nardelli P; Pasin L; Barucco G; Mattioli C; Di Tomasso N; Dalessandro G; Giardina G; Landoni G; Chiesa R; Zangrillo A
Br J Anaesth; 2020 Jan; 124(1):35-43. PubMed ID: 31607387
[TBL] [Abstract][Full Text] [Related]
18. Is tranexamic acid associated with decreased need for blood transfusion in percutaneous nephrolithotomy: a systematic review and meta-analysis.
Prasad S; Sharma G; Devana SK; Kumar S; Sharma S
Ann R Coll Surg Engl; 2023 Feb; 105(2):99-106. PubMed ID: 36720263
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
20. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss and the inflammatory response following enhanced-recovery primary total hip arthroplasty: a randomised clinical trial.
Xie J; Hu Q; Ma J; Huang Q; Pei F
Bone Joint J; 2017 Nov; 99-B(11):1442-1449. PubMed ID: 29092982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
